Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rotavirus vaccine - Bio-Farma/Murdoch-Childrens-Research-Institute

Next Previous
X
Search
Drug Profile

Rotavirus vaccine - Bio-Farma/Murdoch-Childrens-Research-Institute

Alternative Names: RV3 BB; RV3 BB vaccine - Bio Farma/Murdoch Childrens Research Institute; RV3-BB - Bio-Farma/Murdoch-Childrens-Research-Institute; RV3-BB vaccine

Latest Information Update: 04 Dec 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Murdoch Childrens Research Institute
  • Developer Bio Farma Indonesia; Murdoch Childrens Research Institute; PATH
  • Class Attenuated vaccines; Rotavirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Rotavirus infections

Most Recent Events

  • 30 May 2023 PT Bio Farma completes a phase-III clinical trials in Rotavirus infections (In neonates) in Indonesia (PO) (NCT04185545)
  • 09 Sep 2022 PATH and SK Bioscience completes a phase II trial for Rotavirus infections (In neonates, In infants, Prevention) in South Africa (IM) (NCT04344054)
  • 28 May 2021 No recent reports of development identified for phase-I development in Rotavirus-infections(In adolescents, In children, In infants, In neonates, Prevention, In adults) in Indonesia (PO, Drops)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top